India reiterated its commitment to global pharmaceutical standardization at the 15th International Meeting of World Pharmacopoeias (IMWP), being hosted by the Indian Pharmacopoeia Commission (IPC) in association with the World Health Organization (WHO). Reiterating India's position as the "Pharmacy of the World" and the need to provide quality medicines across the globe, Union Minister of State for Health and Family Welfare, Anupriya Patel, reiterated India's commitment to global pharmaceutical harmonization.

Key Highlights:
India's Commitment to Pharmaceutical Standardization:

• Anupriya Patel reiterated India's commitment to global pharmaceutical harmonization.

• Demonstrated India's leadership in making quality medicines accessible across the world.

Regulatory Advances and Global Partnerships:

• India's development in pharmacopoeial science was emphasized by Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, as the need for global regulatory harmonization to increase pharmaceutical quality standards.

• Rajeev Singh Raghuvanshi, IPC Secretary-cum-Scientific Director & Drugs Controller General of India, mentioned the development of India in pharmacopoeial science, including the IP Online platform to provide wider access to Indian Pharmacopoeia standards.

Key Areas of Discussion at the 15th IMWP:

• Review of progress on 14th IMWP recommendations.

• Discussion on impurity assessment (Q3) and ICH Q6 guidelines on monograph specifications.

• Adoption of the IMWP Charter for long-term governance.

• Promoting cooperation among global pharmacopoeias and regulatory bodies.

• Promoting environmental sustainability in the production of pharmaceuticals.

WHO's Appreciation of India's Leadership:
Dr. Roderico H. Ofrin, WHO Representative to India, appreciated India's leadership in setting pharmacopoeial standards and emphasized the need for global regulatory harmonization for patient safety.Quotes of Leaders or Officials:

• Anupriya Patel, Union Minister of State for Health and Family Welfare:

"IMWP is an important platform to enhance international cooperation in pharmacopoeial science and regulatory harmonization to make high-quality medicines accessible across the world."

• Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC & Drugs Controller General of India:

"India continues to lead the world in pharmacopoeial science. Through efforts such as the IP Online platform, we are making Indian Pharmacopoeia standards more accessible and user-friendly."The 15th IMWP, starting on 5th February 2025, will end on 7th February 2025. The discussions are likely to increase international collaboration in pharmaceutical regulation and quality assurance. Decisions of the meeting will determine future cooperation in standard-setting and regulatory harmonization, further solidifying India's role as a world leader in pharmaceutical innovation and safety.